Rapid self-degradable wound surface protection glue and wound surface protection device
By modifying the rapid self-degrading wound protection gel composed of polysaccharide and nucleophilic group-rich polymer, the problem of excessive degradation time of hydrogel is solved, and the rapid degradation and strong adhesion of the wound protection gel is achieved. It is suitable for temporary Protect and rapid drug release, suitable for small wounds and in vivo treatment.
Patent Information
- Application Number
- CN202410967287.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-18
- Publication Date
- 2024-11-12
AI Technical Summary
The degradation time of existing hydrogels is too long, which hinders wound healing and drug release, and is difficult to degrade on its own, making it difficult to be suitable for in vivo treatment.
Fast self-degrading wound protection glue composed of modified polysaccharides and nucleophilic group-rich polymers are modified by oxidation of sodium periodate and combined with suitable pH regulators to form solutions A and solution B, which can degrade itself within 3 days. , suitable for temporary protection and rapid drug release.
It realizes rapid degradation and strong adhesion of wound protection glue, is suitable for small wound protection and rapid drug release, avoids cross-linking problems caused by premature mixing, and is suitable for wound treatment in vivo and in vitro.
Smart Images

Figure CN118924943A_ABST
Abstract
Description
Technical Field
[0001] This invention belongs to the field of medical materials, specifically relating to a rapidly self-degradable wound protectant and a wound protection device containing the wound protectant. Background Technology
[0002] For wounds on the body surface or inside the body, especially surgical wounds on internal organs, hydrogels are used clinically for sealing and protection. In addition to their advantages such as high water absorption, high biocompatibility, and the ability to gel and solidify in situ, hydrogels usually also have a certain degree of degradability, thus eliminating the need for physical removal. For example, when used in vivo, there is no need to surgically remove the gel from the body.
[0003] Because hydrogels typically degrade over a long period, usually a month or even longer, the wound remains covered by the gel throughout this time. This can not only hinder the growth of fibroblasts and other cells at the wound site but also easily trigger or prolong the inflammatory response, especially in shallow, small wounds, thus impeding healing. Furthermore, hydrogels often contain active pharmaceutical ingredients; if degradation is too slow, it can also affect the release of these active ingredients.
[0004] Existing technologies include some rapidly degradable hydrogels. For example, CN202110171647.0 discloses an on-demand dissolvable hydrogel dressing that degrades in response to cysteine, making it easy to replace. However, this dressing requires a cysteine solution to promote dissolution, making it suitable for external wound treatment but difficult for internal use. Furthermore, because it is difficult to degrade on its own, it also requires the use of a cysteine solution when used for external treatment, which is inconvenient. Summary of the Invention
[0005] To address the aforementioned problems, this invention provides a rapidly self-degrading wound protectant, characterized by comprising solution A and solution B. Solution A contains a modified polysaccharide, and solution B contains a nucleophilic polymer. The modified polysaccharide is one or more of modified dextran, modified pullulan, and modified cellulose, with a number-average molecular weight between 20,000 and 200,000, a modification rate of 1%-95%, and a mass concentration of 5% to 50% in solution A. The pH of solution B is 9-12. The rapidly self-degrading wound protectant provided by this invention may also have the technical feature that the modified polysaccharide is obtained through oxidative modification with sodium periodate. Furthermore, the nucleophilic polymer may be one or more of polymers such as trilysine, polylysine, polyarginine, polycysteine, and polyethyleneimine.
[0006] Furthermore, the rapidly self-degradable wound protectant provided by the present invention may also have the following technical feature: solution B further contains a pH adjuster, which is one or more of the following: hydrochloric acid, sodium carbonate, sodium bicarbonate, potassium carbonate, potassium bicarbonate, disodium hydrogen phosphate, sodium dihydrogen phosphate, dipotassium hydrogen phosphate, potassium dihydrogen phosphate, sodium hydroxide, and potassium hydroxide.
[0007] Furthermore, the rapidly self-degrading wound protectant provided by the present invention may also have the following technical feature: the solvents of solution A and solution B are any one of purified water, water for injection, physiological saline, or PBS buffer.
[0008] The present invention also provides a wound protection device, comprising a wound protection adhesive as described in any of the above claims and a dual-drug delivery device, wherein the two reagent cartridges of the dual-drug delivery device respectively contain solution A and solution B.
[0009] Invention Function and Effect
[0010] The rapidly self-degrading wound protectant provided by the present invention has the advantages of large coverage thickness and strong adhesion compared to other gels. It can rapidly self-degrade within 3 days without the need for other reagent treatment, making it suitable for temporary protection, protection of small wounds, and situations requiring rapid release of drug components. Solution A contains modified polysaccharides, specifically a mixture of one or more of modified dextran, modified pullulan, and modified cellulose. The number average molecular weight of the modified polysaccharides is between 20,000 and 200,000, with a modification rate of 1%-95%. The modified polysaccharides account for 5% to 50% of the mass concentration in solution A, and the pH of solution B is 9-12. Attached Figure Description
[0011] Figure 1 This is a photograph of the actual double-unit mixing device used in this invention.
[0012] Figure 2 This is a photograph of the cured adhesive in the thickness test of the wound protection adhesive in Experiment Group 1 of this invention.
[0013] Figure 3 This is a photograph of the actual colloid after rinsing in the tissue adhesion test of the wound protection adhesive in Experiment Group 1 of this invention.
[0014] Figure 4 These are photographs of the actual colloids of experimental group 1 and control group 1 after being placed in an oven at 37°C for 6 hours during the degradation time test of the wound protective colloids in the embodiment of the present invention. Detailed Implementation
[0015] The following examples illustrate the rapidly self-degradable wound protectant and its preparation method according to the present invention. In the following examples, reagents and materials whose source is not specified are all commercially available, and operational methods not specifically described refer to conventional operating methods in the prior art.
[0016] The following examples use modified dextran, modified pullulan, and modified cellulose. The specific modification methods for each raw material are as follows:
[0017] 1. Synthesis of modified dextran
[0018] Dissolve 5g of a number-average molecular weight dextran of 20,000 in 100mL of pure water and stir until the dextran is completely dissolved. Weigh 5g of sodium periodate and add it to a spherical flask, then stir and react overnight. Subsequently, place the solution in a 3L beaker and dialyze it with pure water for 3 days to remove small molecule byproducts. Freeze-dry the dialyzed solution to obtain modified dextran with a modification rate of 40%.
[0019] Furthermore, by using dextran raw materials with different number-average molecular weights to perform the above modification steps, modified dextran with different molecular weights can be obtained; by changing the amount of sodium periodate added (relative to the amount of dextran), modified dextran with different modification rates can be obtained.
[0020] 2. Synthesis of modified pullulan polysaccharide
[0021] Dissolve 4g of pullulan (100,000 number-average molecular weight) in 100mL of pure water and stir until completely dissolved. Weigh 5g of sodium periodate and add it to a spherical flask, stirring and reacting overnight. Then, place the solution in a 3L beaker and dialyze it with pure water for 3 days to remove small molecule byproducts. Freeze-dry the dialyzed solution to obtain modified pullulan with a modification rate of 50%.
[0022] 3. Modified cellulose synthesis
[0023] 2g of cellulose with a number average molecular weight of 200,000 was dispersed in 100mL of pure water. 10g of sodium periodate was weighed and added to a spherical flask, and the mixture was stirred and reacted overnight. Subsequently, the solution was placed in a 3L beaker and dialyzed with pure water for 3 days to remove small molecule byproducts. The dialyzed solution was then freeze-dried to obtain modified cellulose with a modification rate of 95%.
[0024] Example: Formulation of wound protective adhesive
[0025] This embodiment provides a wound protective gel composed of different solutions A and B. The specific preparation process includes the following steps:
[0026] Step S1: Prepare solution A containing modified polysaccharides. By using different types of modified polysaccharides and adding different amounts of water solvent, different groups of solutions A can be obtained. The composition of each group of solutions A is shown in Table 1 below:
[0027] Table 1. Composition and concentration of solution A in different groups
[0028] Group Types of polysaccharides Polysaccharide molecular weight Polysaccharide modification rate mass concentration Water-soluble A1 Modified dextran 20000 40% 25% Purified water A2 Modified dextran 20000 40% 15% Purified water A3 Modified dextran 20000 20% 25% Purified water A4 Modified dextran 70000 40% 25% Purified water
[0029] Step S2 involves preparing solution B containing a polysaccharide nucleophilic polymer. By using different types of polysaccharide nucleophilic polymers, adding different amounts of water solvent, and using different pH adjusters to adjust the final pH of the solution to different values, different groups of solutions B can be obtained. The composition and pH of each group of solutions B are shown in Table 2 below.
[0030] Table 2. Composition and pH of solution B in different groups
[0031] Group Polysaccharide nucleophilic polymers mass concentration pH pH adjuster Water-soluble B1 Polylysine 10% 11 Potassium bicarbonate Purified water B2 Polylysine 10% 9 Sodium carbonate Purified water B3 Polylysine 30% 11 Sodium hydroxide Purified water B4 Polylysine 10% 9 Sodium hydroxide Purified water B5 Polylysine 30% 9 Sodium hydroxide Purified water B6 Polylysine 10% 7.5 Sodium hydroxide Purified water B7 Polylysine 30% 7.5 Sodium hydroxide Purified water B8 Polylysine 30% 6.5 Sodium hydroxide Purified water
[0032] Step S3: Mix solution A and solution B to allow them to solidify and crosslink, resulting in different wound protection adhesives.
[0033] In this embodiment, different wound protection adhesives were prepared according to the combinations in Table 3 below:
[0034] Table 3 shows the component composition of the wound care adhesive in the examples.
[0035] Group Component combination Experimental group 1 Component A1 / Component B1 Experimental group 2 Component A2 / Component B2 Experimental group 3 Component A3 / Component B3 Experimental group 4 Component A4 / Component B4 Experimental group 5 Component A2 / Component B5
[0036] In addition, several wound care adhesives were prepared according to the combinations in Table 4 below as a control group:
[0037] Table 4. Component composition of the wound protection gel in the comparison group.
[0038] Group Component combination Comparison Group 1 Component A1 / Component B6 Comparison Group 2 Component A2 / Component B7 Comparison Group 3 Component A3 / Component B8
[0039] Test Example 1: Gel Formation Test of Wound Protective Adhesive
[0040] This example demonstrates the gelation time test of different wound protection adhesives prepared in the previous example.
[0041] The specific procedure is as follows: Take 1 mL of each of the different groups of solution A and solution B, spray them onto the petri dish using a doublet mixer, and record the gelation time after the two components come into contact.
[0042] Figure 1 This is a photograph of the actual double-unit mixing device used in this invention.
[0043] like Figure 1As shown, the dual-tube mixer has two reagent cartridges with a structure similar to a syringe, each with a nozzle at its end. The nozzles on both cartridges face the same direction, and the push rods of the two cartridges are connected by a connecting rod, allowing them to be pushed simultaneously. Therefore, solutions A and B can be loaded into different reagent cartridges, and by simultaneously pushing the push rods of both cartridges, solutions A and B can be sprayed at the same time, forming a mixture.
[0044] The gelation times of different wound care adhesives prepared by mixing solutions A and B in different combinations are shown in Table 5 below:
[0045] Table 5. Gel formation time of different wound care adhesives
[0046] Group Gel formation time (s) Experimental group 1 <5 Experimental group 2 8 Experimental group 3 9 Experimental group 4 <5 Experimental group 5 <5 Comparison Group 1 12 Comparison Group 2 7 Comparison Group 3 18
[0047] Test Example 2: Coverage Thickness Test of Wound Protective Adhesive
[0048] This example demonstrates the gelation time test of different wound protection adhesives prepared in the previous example.
[0049] The specific procedure is as follows: Take 1 mL each of solution A and solution B from different groups, and spray them vertically onto a petri dish using a dual-stage mixer (the distance between the spray head and the petri dish remains constant during spraying, and the spray direction is perpendicular to the plane of the petri dish). Continue spraying until all the solutions have been sprayed. After complete cross-linking and curing, measure the thickness of the cured colloid.
[0050] Figure 2 This is a photograph of the cured adhesive in the thickness test of the wound protection adhesive in Experiment Group 1 of this invention.
[0051] like Figure 2 As shown, the wound protection adhesive in experimental group 1 has a certain coverage thickness, and it can play a good role in wound protection when used in practice.
[0052] The coverage thickness of different wound protective adhesives prepared by mixing different combinations of solutions A and B is shown in Table 6 below:
[0053] Table 6 Coverage Thickness of Different Wound Protective Adhesives
[0054] Group Coverage thickness (mm) Experimental group 1 11 Experimental group 2 6 Experimental group 3 4 Experimental group 4 10 Experimental group 5 11 Comparison Group 1 4 Comparison Group 2 7 Comparison Group 3 2
[0055] Test Example 3: Tissue Adhesion Test of Wound Protective Adhesive
[0056] This embodiment is a tissue adhesion test of different wound protection adhesives prepared in the previous embodiment.
[0057] The specific procedure is as follows: Cut the air-dried bovine casings into small sections of approximately 8 cm. Before use, soak them in 37°C warm water for 30 minutes, then cut them in half to form rectangular pieces. Take 0.5 mL each of solutions A and B from different groups and spray them onto the center of the casings using a double-mixer. Let them stand at room temperature for 30 minutes. Then, rinse off any unadhesive adhesive with pure water, lay them flat on one end of a glass funnel, fix them with clamps, adjust the flow rate of the peristaltic pump to 20 ml / min, and rinse with pure water for 5 minutes. Collect the rinsing solution in an evaporating dish of known mass, dry it, and weigh it. The tissue adhesion force is expressed as an adhesion percentage (Bg / %), calculated as follows:
[0058] Bg / % = {[M-(Ggm)] / M} x 100%
[0059] In the above formula, M is the weight of the protective adhesive (0.5 ml dried under the same conditions); g is the weight of the evaporating dish; G is the total weight of the beaker and the residue after drying; m is the amount of solid matter contained in the same volume of rinsing solution (blank control group, i.e., the rinsing solution obtained by directly placing the casings on the surface without using protective adhesive and then rinsing with pure water). The higher the percentage of adhesion, the greater the adhesion.
[0060] Figure 3 This is a photograph of the actual colloid after rinsing in the tissue adhesion test of the wound protection adhesive in Experiment Group 1 of this invention.
[0061] like Figure 3 As shown, after rinsing with running water for five minutes, the wound protection adhesive sample was still visible on the casing, indicating that it has strong adhesion and is not easy to fall off when applied to the wound, thus playing a better protective role.
[0062] The tissue adhesion percentages of different wound protective adhesives prepared by mixing solutions A and B in different combinations are shown in Table 7 below:
[0063] Table 7. Tissue adhesion percentage of different wound care adhesives
[0064] Group Adhesion percentage (%) Experimental group 1 >95 Experimental group 2 92 Experimental group 3 80 Experimental group 4 >95 Experimental group 5 84 Comparison Group 1 >95 Comparison Group 2 87 Comparison Group 3 80
[0065] Test Example 4: Degradation Time Test of Wound Protective Adhesive
[0066] This example demonstrates the degradation time test of different wound protection adhesives prepared in the previous example.
[0067] The specific procedure is as follows: Take 1 mL of each of solutions A and B from different groups, spray them onto a petri dish using a doublet mixer, wait 10 minutes, then accurately weigh 1 g of the colloidal sample and place it in a centrifuge tube. Add 20 mL of physiological saline, place the tube in a 37°C oven, and observe the colloidal condition periodically. When no obvious colloidal residue is found, and the remaining weight after drying and weighing the centrifuge tube (weight after removing the centrifuge tube's own weight) is less than 0.01 g, it is considered completely degraded. Record the time required for complete degradation, which is the degradation time.
[0068] Figure 4 These are photographs of the wound protective adhesives of Experimental Group 1 and Control Group 1 after being placed in a 37°C oven for 6 hours during the degradation time test according to embodiments of the present invention. The left side represents Control Group 1, and the right side represents Experimental Group 1.
[0069] like Figure 4 As shown, the colloidal sample on the left was not completely degraded, while the colloidal sample on the right had dissolved in the saline solution. This indicates that the wound protection gel in experimental group 1 degrades very quickly under human physiological conditions, while the control group degrades much more slowly.
[0070] The degradation times of different wound protective adhesives prepared by mixing solutions A and B in different combinations are shown in Table 8 below:
[0071] Table 8 Degradation time of different wound care adhesives
[0072]
[0073]
[0074] The role and effect of the embodiments
[0075] Based on the data results of Test Examples 1-3 above, it can be seen that the wound protective adhesives of different experimental groups and different control groups can form gels in a relatively short time and achieve a certain coverage thickness and tissue adhesion. However, according to the data results of Test Example 4, the degradation time of each experimental group is significantly shorter than that of each control group. Further comparison with the differences between solutions A and B in each experimental group and control group shows that the pH of solution B in each experimental group is higher than that in each control group, indicating that the pH of solution B has a greater impact on the degradation time. In addition, the inventors of this invention also used modified pullulan, modified cellulose, and other modified polysaccharides, as well as other polysaccharide nucleophilic polymers such as polyarginine, polycysteine, and polyethyleneimine to conduct the same wound protective adhesive formulation and degradation time test. It was found that the wound protective adhesives prepared by these modified polysaccharides and polysaccharide nucleophilic polymers also showed that pH has a significant impact on the degradation time. Therefore, setting the pH of solution B to 9 or above can yield a wound protective adhesive that is easy to degrade.
[0076] The differences in degradation time among the experimental groups in Test Example 4 also show that the molecular weight, concentration, and modification rate of the modified polysaccharide, as well as the concentration of the polysaccharide nucleophilic polymer, have a certain impact on the degradation time. However, when the pH reaches above 9, the degradation time can be controlled within 3 days. Therefore, the degradation time of the wound protectant in each experimental group is relatively short, making it very suitable for occasions that require rapid degradation, such as small and shallow wounds, wounds that require temporary protection, or occasions that require rapid drug release, etc.
[0077] Furthermore, during use, pre-prepared solutions A and B can be contained separately in different reagent cartridges of the dual-application device. The dual-application device can then simultaneously apply solutions A and B to the wound, allowing them to mix and cross-link in situ, solidifying into a gel. Compared to mixing solutions A and B in a container before application, this dual-application device method avoids the problem of premature cross-linking and compromised tissue adhesion caused by pre-mixing, as solutions A and B do not come into contact with each other before reaching the wound.
Claims
1. A fast self-degradable wound protection glue, characterized in that: Including solution A and solution B, Wherein, the solution A contains modified polysaccharide, and the solution B contains a polymer rich in nucleophilic groups, The modified polysaccharide is a mixture of one or more of modified dextran, modified pullulan, and modified cellulose. The number average molecular weight of the modified polysaccharide is between 20,000 and 200,000, and the modification rate is 1%-95%. The mass concentration of the modified polysaccharide in solution A is 5% to 50%. The pH of the solution B is 9-12.
2. The fast self-degradable wound protection glue according to claim 1, characterized in that: in, The modified polysaccharide is obtained by oxidation modification with sodium periodate.
3. The fast self-degradable wound protection glue according to claim 1, characterized in that: in, The nucleophilic group-rich polymer is one or a mixture of trilysine, polylysine, polyarginine, polycysteine and polyethyleneimine.
4. The fast self-degradable wound protection glue according to claim 1, characterized in that: in, The solution B further contains a pH regulator, which is a mixture of one or more of hydrochloric acid, sodium carbonate, sodium bicarbonate, potassium carbonate, potassium bicarbonate, disodium hydrogen phosphate, sodium dihydrogen phosphate, dipotassium hydrogen phosphate, potassium dihydrogen phosphate, sodium hydroxide, and potassium hydroxide.
5. The fast self-degradable wound protection glue according to claim 1, characterized in that: in, The solvent of the solution A and the solution B is any one of purified water, water for injection, physiological saline or PBS buffer.
6. A wound protection device, characterized in that: include: The wound protection glue according to any one of claims 1 to 5; as well as Double drug delivery device, The two reagent cartridges of the dual-dose dispenser contain the solution A and the solution B respectively.
